Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 196-204 , May 2006

Systemic IGF-I treatment inhibits cell death in diabetic rat retina

  • Gail M. Seigel

      Affiliations

    • Department of Ophthalmology, University at Buffalo, Buffalo, NY, USA
    • Ross Eye Institute, Department of Opthalmology, University of Buffalo, Buffalo, NY, USA
    • Corresponding Author InformationCorresponding author. Department of Ophthalmology, Physiology and Biophysics, University at Buffalo, the State University of New York, 3435 Main Street, Sherman 124, Buffalo, NY 14214, USA. Tel.: +1 716 829 2157; fax: +1 716 829 2344.
    • ,
  • Sean B. Lupien

      Affiliations

    • Department of Biomedical Sciences, Colorado State University, Ft. Collins, CO, USA
    • Department of Biochemistry and Molecular Biology, Colorado State University, Ft. Collins, CO, USA
    • ,
  • Lorrie M. Campbell

      Affiliations

    • Department of Ophthalmology, University at Buffalo, Buffalo, NY, USA
    • ,
  • Douglas N. Ishii

      Affiliations

    • Department of Biomedical Sciences, Colorado State University, Ft. Collins, CO, USA
    • Department of Biochemistry and Molecular Biology, Colorado State University, Ft. Collins, CO, USA

Received 26 August 2004 ,Revised 28 January 2005 ,Accepted 20 June 2005.

References 

  1. Acerini CL, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB. Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet. 1997;350:1199–1204
  2. Armstrong CS, Wuarin L, Ishii DN. Uptake of circulating insulin-like growth factor-I into the cerebrospinal fluid of normal and diabetic rats, and normalization of IGF-II mRNA content in diabetic rat brain. Journal of Neuroscience Research. 2000;59:649–660
  3. Bagley CJ, May B, Szabo L, McNamara PJ, Ross M, Francis GL, et al. A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide. Biochemistry Journal. 1989;259:665–671
  4. Barber A, Nakamura M, Wolpert EB, Reiter C, Seigel GM, Antonetti DA, et al. Insulin rescues retinal neurons from apoptosis by a phosphotidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. Journal of Biological Chemistry. 2001;276(35):32814–32821
  5. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. Journal of Clinical Investigation. 1998;102:783–791
  6. Beck K, Powell-Braxton L, Widmer H, Valverde J, Hefti F. IGF1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 1995;14:717–730
  7. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: Implications for brain function. European Journal of Pharmacology. 2002;441:1–14
  8. Bode C, Wolfrum U. Caspase-3 inhibitor reduces apoptotic photoreceptor cell death during inherited retinal degeneration in tubby mice. Molecular Vision. 2003;9:144–150
  9. Bodkin NL, Sportsman R, DiMarchi RD, Hansen BC. Insulin-like growth factor I in non-insulin-dependent diabetic monkeys: Basal plasma concentrations and metabolic effects of exogenously administered biosynthetic hormone. Metabolism. 1991;40:1131–1137
  10. Burgos R, Mateo C, Canton A, Hernandez C, Mesa J, Simo R. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy. Diabetes Care. 2000;23:80–83
  11. Chen TA, Yang F, Cole GM, Chan SO. 2004 Inhibition of caspase-3-like activity reduces glutamate induced cell death in adult rat retina. Brain Research. 2001;904:177–188
  12. Clemmons DR, Camacho-Hubner C, McCusker RH, Bayne ML. Discrete alterations of the insulin-like growth factor I molecule which alters its affinity for insulin-like growth factor binding proteins in changes in bioactivity. Journal of Biological Chemistry. 1990;265:12210–12216
  13. Condorelli G, Roncarati R, Ross J, Pisani A, Stassi G, Todaro M, et al. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:9977–9982
  14. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: The Oslo Study. British Medical Journal (Clin Res Ed). 1985;290(6471):811–815
  15. de Pablo F, de la Rosa EJ. The developing CNS: A scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosciences. 1995;18:143–150
  16. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. The role of insulin-like growth factors in the central nervous system. Molecular Neurobiology. 1996;13:227–255
  17. Fagin JA, Roberts CT, LeRoith D, Brown AT. Coordinate decrease of tissue insulin-like growth factor I posttranscriptional alternative mRNA transcripts in diabetes mellitus. Diabetes. 1989;38:428–434
  18. Fernandez AM, Gonzalez de la Vega A, Torres-Aleman I. Insulin-like growth factor restores motor coordination in a rat model of cerebellar ataxia. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:1253–1258
  19. Galvan V, Logvinova A, Sperandio S, Ichijo H, Bredesen DE. Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1). Journal of Biological Chemistry. 2003;278:13325–13332
  20. Gavrieli Y, Sherman Y, Ben SS. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. Journal of Cell Biology. 1992;119:493–501
  21. Gerhardinger C, McClure KD, Romero G, Podesta F, Lorenzi M. IGF-I mRNA and signaling in the diabetic retina. Diabetes. 2001;50:175–183
  22. Glazner GW, Lupien S, Miller JA, Ishii DN. Insulin-like growth factor-II increases the rate of sciatic nerve regeneration in rats. Neuroscience. 1993;54:791–797
  23. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes. 1998;47:401–406
  24. Ishii DN. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Research Reviews. 1995;20(1):47–67
  25. Ishii DN, Guertin DM, Whalen LR. Reduced insulin-like growth factor I mRNA content in liver, adrenal glands and spinal cord of diabetic rats. Diabetologia. 1994;37:1073–1081
  26. Ishii DN, Lupien SB. Insulin-like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats. Journal of Neuroscience Research. 1995;40:138–144
  27. Ishii DN, Pu S-F. Neuropharmacology of insulin-like growth factors. Handbook of Experimental Pharmacology. 1999;134:119–146
  28. Ismail GM, Whitaker D. Early detection of changes in visual function in diabetes mellitus. Ophthalmic & Physiological Optics. 1998;18:3–12
  29. Kamijo M, Cherian PV, Sima AAF. The preventive effects of aldose reductase inhibition on diabetic optic neuropathy in the BB/W rat. Diabetologia. 1993;36:893–898
  30. Kondo T, Kahn CR. Altered insulin signaling in retinal tissue in diabetic states. The Journal of Biological Chemistry. 2004;279:37997–38006
  31. Korolkiewicz RP, Tashima K, Fujita A, Kato S, Takeuchi K. Exogenous insulin-like growth factor (IGF)-1 improves the impaired healing of gastric mucosal lesions in diabetic rats.. Pharmacological Research. 2000, Feb.;41(2):221–229
  32. Kowluru RA, Koppolu P. Diabetes-induced activation of caspase-3 in retina: Effect of antioxidant therapy. Free Radical Research. 2002;36:993–999
  33. Kummer A, Pulford B, Ishii DN, Seigel GM. Des(1–3) IGF-1 treatment normalizes IGF-1 and type 1 IGF receptor immunoreactivity in pre-degenerative retina of diabetic rats. International Journal of Experimental Diabetes Research. 2003;4(1):45–57
  34. Laron Z, Weinberger D. Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome). European Journal of Endocrinology. 2004;151:103–106
  35. Lowe WL, Florkiewicz RZ, Yorek MA, Spanheimer RG, Albrecht BN. Regulation of growth factor mRNA levels in the eyes of diabetic rats. Metabolism. 1995;44:1038
  36. Lupien SB, Bluhm EJ, Ishii DN. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. Journal of Neuroscience Research. 2003;74:512–523
  37. Mapstone R, Clark CV. Prevalence of diabetes in glaucoma. British Medical Journal (Clin Res Ed). 1985;291:93–95
  38. McCall AL. The impact of diabetes on the CNS. Diabetes. 1991;41:557–570
  39. McGuinness R. Association of diabetes and cataract. British Medical Journal. 1967;2:416–418
  40. Migdalis IN, Kalogeropoulou K, Kalantzis L, Nounopoulos C, Bouloukos A, Samartzis M. Insulin-like growth factor-I and IGF-I receptors in diabetic patients with neuropathy. Diabetic Medicine. 1995;12:823–827
  41. Mooradian AD. Diabetic complications of the central nervous system. Endocrine Reviews. 1988;9:346–356
  42. Near SL, Whalen LR, Miller JA, Ishii DN. Insulin-like growth factor II stimulates motor nerve regeneration in rats. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:11716–11720
  43. Neff NT, Prevette D, Houenou LJ, Lewis ME, Glicksman MA, Yin QW, et al. Insulin-like growth factors: Putative muscle-derived trophic agents that promote motoneuron survival. Journal of Neurobiology. 1993;24:1578–1588
  44. Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, et al. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia. 2003, Sep.;46(9):1260–1268
  45. Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H. Growth factor alterations in advanced diabetic retinopathy: A possible role of blood retina barrier breakdown. Diabetes. 1997;46(Suppl. 2):S26–S30
  46. Phillips LS, Goldstein S, Pao CI. Nutrition and somatomedin: XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes. 1991;40:1525–1530
  47. Politi LE, Rotstein NP, Salvador G, Giusto NM, Insa MF. Insulin-like growth factor-I is a potential trophic factor for amacrine cells. Journal of Neurochemistry. 2001;76:1199–1211
  48. Porta M. Diabetic retinopathy and metabolic control. European Journal of Ophthalmology. 1993;3:207–215
  49. Poulaki V, Joussen AM, Mitsiades N, Mitsiades CS, Iliaki EF, Adamis AP. Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. American Journal of Pathology. 2004;165:457–469
  50. Pu S-F, Zhuang HX, Marsh DJ, Ishii DN. Insulin-like growth factor-II increases and IGF is required for postnatal rat spinal motoneuron survival following sciatic nerve axotomy. Journal of Neuroscience Research. 1999;55:9–16
  51. Recio-Pinto E, Rechler MM, Ishii DN. Effects of insulin, insulinlike growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons. Journal of Neuroscience. 1986;6:1211–1219
  52. Sakai H, Tani Y, Shirasawa E, Shirao Y, Kawasaki K. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. Ophthalmic Research. 1995;27:57–63
  53. Schmidt RE, Dorsey DA, Beaudet LN, Plurad SB, Parvin CA, Miller MS. Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy. American Journal of Pathology. 1999;155:1651–1660
  54. Seigel GM, Chiu L, Paxhia A. Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs. Molecular Vision. 2000;6:157–163
  55. Sharp P. The role of growth factors in the development of diabetic retinopathy. Metabolism. 1995;44(10):72–75
  56. Simo R, Lecube A, Segura RM, Garcia Arumi J, Hernandez C. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. American Journal of Ophthalmology. 2002;134(3):376–382
  57. Spranger J, Buhnen J, Jansen V, Krieg M, Meyer-Schwickerath R, Blum WF, et al. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy. Hormone and Metabolic Research. 2000;32:196–200
  58. Tan K, Baxter RC. Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age. The Journal of Clinical Endocrinology and Metabolism. 1986;63:651–655
  59. Tang J, Mohr S, Du Y, Kern TS. Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Current Eye Research. 2003;27:7–13
  60. Thomas PK, Tomlinson DR. Diabetic and hypoglycemic neuropathy. In:  Dyck PJ,  Thomas PK,  Griffin JW,  Low PA,  Poduslo JF editor. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders; 1993;p. 1219–1250
  61. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Annals of Internal Medicine. 1997, Nov. 1;127(9):788–795
  62. Vinik AI, Newlon P, Milicevic Z, McNitt P, Stansberry KB. Diabetic neuropathies: An overview of clinical aspects. In:  LeRoith D,  Taylor SI,  Olefsky JM editor. Diabetes mellitus: A fundamental and clinical text. Philadelphia: Lippincott-Raven; 1996;p. 737
  63. Wuarin L, Guertin DM, Ishii DN. Reduction in insulin-like growth factor (IGF) gene expression in nerves precedes the onset of diabetic neuropathy. Experimental Neurology. 1994;130:106–114
  64. Wuarin L, Namdev R, Burns JG, Fei Z-J, Ishii DN. Brain insulin-like growth factor-II mRNA content is reduced in insulin-dependent and non-insulin-dependent diabetes mellitus. Journal of Neurochemistry. 1996;67:742–751
  65. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. The Journal of Pathology. 1984;142:67–77
  66. Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Visual Neuroscience. 2000;17:463–471
  67. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 2001, Jul.;24(7):1275–1279
  68. Zhuang H-X, Snyder CK, Pu S-F, Ishii DN. Insulin-like growth factors reverse or arrest diabetic neuropathy: Effects on hyperalgesia and impaired nerve regeneration in rats. Experimental Neurology. 1996;140:198–205
  69. Zhuang H-X, Wuarin L, Fei Z-J, Ishii DN. Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy. The Journal of Pharmacology and Experimental Therapeutics. 1997;283:366–374

PII: S1056-8727(05)00076-0

doi: 10.1016/j.jdiacomp.2005.06.007

Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 196-204 , May 2006

Article Tools

* Image Usage & Resolution